73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
New drug delays progression of glioma, a deadly brain cancer, during clinical trial

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend
New study highlights rapid adoption of clinical research results into chemotherapy prescribing patterns

New study highlights rapid adoption of clinical research results into chemotherapy prescribing patterns

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research inJNCCN—Journal of the National Comprehensive Cancer Networkevaluates how an important analysis on loc

New study highlights rapid adoption of clinical research results into chemotherapy prescribing patterns

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research inJNCCN—Journal of the National Comprehensive Cancer Networkevaluates how an important analysis on loc
New method reveals insights into interplay between immune system and tumors

New method reveals insights into interplay between immune system and tumors

by Mallory Locklear,Yale UniversitySingle cell genomics reveals multiple human immune cell types in tumors and blood of autologous MISTRG6 PDX mice, including innate immune cell types present in

New method reveals insights into interplay between immune system and tumors

by Mallory Locklear,Yale UniversitySingle cell genomics reveals multiple human immune cell types in tumors and blood of autologous MISTRG6 PDX mice, including innate immune cell types present in
Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines

Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAmong individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for h

Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAmong individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for h
Study finds cancer cells use a new fuel in absence of sugar

Study finds cancer cells use a new fuel in absence of sugar

by Anna Megdell,University of MichiganProfiling of metabolite utilization in PDA cells identifies uridine. Credit:Nature(2023). DOI: 10.1038/s41586-023-06073-wResearchers at the Univ

Study finds cancer cells use a new fuel in absence of sugar

by Anna Megdell,University of MichiganProfiling of metabolite utilization in PDA cells identifies uridine. Credit:Nature(2023). DOI: 10.1038/s41586-023-06073-wResearchers at the Univ
Fighting liver cancer takes big financial toll: Study

Fighting liver cancer takes big financial toll: Study

by Cara MurezOut-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.While Medicare payments in the first year after diagnosis withhepatoc

Fighting liver cancer takes big financial toll: Study

by Cara MurezOut-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.While Medicare payments in the first year after diagnosis withhepatoc
Discovery adds to evidence that some children are predisposed to develop leukemia

Discovery adds to evidence that some children are predisposed to develop leukemia

by St. Jude Children's Research HospitalCharles Mullighan, MBBS, M.D., Michelle Churchman Ph.D., Max Qian PhD, Jun Yang Ph.D. Credit: St. Jude Children's Research Hospital / Seth DixonSt.

Discovery adds to evidence that some children are predisposed to develop leukemia

by St. Jude Children's Research HospitalCharles Mullighan, MBBS, M.D., Michelle Churchman Ph.D., Max Qian PhD, Jun Yang Ph.D. Credit: St. Jude Children's Research Hospital / Seth DixonSt.
Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d
Doctors and molecular engineers working to enlist the immune system to fight cancer

Doctors and molecular engineers working to enlist the immune system to fight cancer

by Sharla A. Paul,University of ChicagoT cells attacking cancer. Credit: royaltystockphotoWhen telling the story of immunotherapy and cancer and how the two battle it out, it's awfully chall

Doctors and molecular engineers working to enlist the immune system to fight cancer

by Sharla A. Paul,University of ChicagoT cells attacking cancer. Credit: royaltystockphotoWhen telling the story of immunotherapy and cancer and how the two battle it out, it's awfully chall
New study explores challenges and opportunities for cancer research

New study explores challenges and opportunities for cancer research

by Richard Harth,Arizona State UniversityA recent review by Carlo Maley, a researcher at Arizona State University, and Lucie Laplane from the University of Paris Pantheon-Sorbonne critiques the

New study explores challenges and opportunities for cancer research

by Richard Harth,Arizona State UniversityA recent review by Carlo Maley, a researcher at Arizona State University, and Lucie Laplane from the University of Paris Pantheon-Sorbonne critiques the
Small molecule drug reverses ADAR1-induced cancer stem cell cloning capacity

Small molecule drug reverses ADAR1-induced cancer stem cell cloning capacity

byUniversity of California - San DiegoA colorized scanning electron micrograph depicts human red blood cells. Credit: UC San Diego Health SciencesResearchers at University of California San Dieg

Small molecule drug reverses ADAR1-induced cancer stem cell cloning capacity

byUniversity of California - San DiegoA colorized scanning electron micrograph depicts human red blood cells. Credit: UC San Diego Health SciencesResearchers at University of California San Dieg